<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Publishing DTD v2.3 20070202//EN" "journalpublishing.dtd">
<article article-type="research-article" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xml:lang="EN">
<front>
<journal-meta>
<journal-id journal-id-type="publisher-id">Front. Cardiovasc. Med.</journal-id>
<journal-title>Frontiers in Cardiovascular Medicine</journal-title>
<abbrev-journal-title abbrev-type="pubmed">Front. Cardiovasc. Med.</abbrev-journal-title>
<issn pub-type="epub">2297-055X</issn>
<publisher>
<publisher-name>Frontiers Media S.A.</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="doi">10.3389/fcvm.2024.1410616</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Cardiovascular Medicine</subject>
<subj-group>
<subject>Original Research</subject>
</subj-group>
</subj-group>
</article-categories>
<title-group>
<article-title>Exploring the effects of real-time online cardiac telerehabilitation using wearable devices compared to gym-based cardiac exercise in people with a recent myocardial infarction: a randomised controlled trial</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author"><name><surname>Mitropoulos</surname><given-names>A.</given-names></name>
<xref ref-type="aff" rid="aff1"><sup>1</sup></xref>
<xref ref-type="aff" rid="aff2"><sup>2</sup></xref><uri xlink:href="https://loop.frontiersin.org/people/2240642/overview"/><role content-type="https://credit.niso.org/contributor-roles/conceptualization/"/><role content-type="https://credit.niso.org/contributor-roles/formal-analysis/"/><role content-type="https://credit.niso.org/contributor-roles/methodology/"/><role content-type="https://credit.niso.org/contributor-roles/writing-original-draft/"/><role content-type="https://credit.niso.org/contributor-roles/writing-review-editing/"/></contrib>
<contrib contrib-type="author"><name><surname>Anifanti</surname><given-names>M.</given-names></name>
<xref ref-type="aff" rid="aff1"><sup>1</sup></xref><role content-type="https://credit.niso.org/contributor-roles/conceptualization/"/><role content-type="https://credit.niso.org/contributor-roles/formal-analysis/"/><role content-type="https://credit.niso.org/contributor-roles/methodology/"/><role content-type="https://credit.niso.org/contributor-roles/writing-original-draft/"/><role content-type="https://credit.niso.org/contributor-roles/writing-review-editing/"/></contrib>
<contrib contrib-type="author"><name><surname>Koukouvou</surname><given-names>G.</given-names></name>
<xref ref-type="aff" rid="aff1"><sup>1</sup></xref><role content-type="https://credit.niso.org/contributor-roles/conceptualization/"/><role content-type="https://credit.niso.org/contributor-roles/formal-analysis/"/><role content-type="https://credit.niso.org/contributor-roles/methodology/"/><role content-type="https://credit.niso.org/contributor-roles/writing-original-draft/"/><role content-type="https://credit.niso.org/contributor-roles/writing-review-editing/"/></contrib>
<contrib contrib-type="author"><name><surname>Ntovoli</surname><given-names>A.</given-names></name>
<xref ref-type="aff" rid="aff3"><sup>3</sup></xref>
<xref ref-type="aff" rid="aff4"><sup>4</sup></xref><role content-type="https://credit.niso.org/contributor-roles/formal-analysis/"/><role content-type="https://credit.niso.org/contributor-roles/methodology/"/><role content-type="https://credit.niso.org/contributor-roles/writing-original-draft/"/><role content-type="https://credit.niso.org/contributor-roles/writing-review-editing/"/></contrib>
<contrib contrib-type="author"><name><surname>Alexandris</surname><given-names>K.</given-names></name>
<xref ref-type="aff" rid="aff3"><sup>3</sup></xref><uri xlink:href="https://loop.frontiersin.org/people/1313562/overview" /><role content-type="https://credit.niso.org/contributor-roles/formal-analysis/"/><role content-type="https://credit.niso.org/contributor-roles/methodology/"/><role content-type="https://credit.niso.org/contributor-roles/writing-original-draft/"/><role content-type="https://credit.niso.org/contributor-roles/writing-review-editing/"/></contrib>
<contrib contrib-type="author" corresp="yes"><name><surname>Kouidi</surname><given-names>E.</given-names></name>
<xref ref-type="aff" rid="aff1"><sup>1</sup></xref>
<xref ref-type="corresp" rid="cor1">&#x002A;</xref><uri xlink:href="https://loop.frontiersin.org/people/1379534/overview" /><role content-type="https://credit.niso.org/contributor-roles/conceptualization/"/><role content-type="https://credit.niso.org/contributor-roles/formal-analysis/"/><role content-type="https://credit.niso.org/contributor-roles/methodology/"/><role content-type="https://credit.niso.org/contributor-roles/supervision/"/><role content-type="https://credit.niso.org/contributor-roles/writing-original-draft/"/><role content-type="https://credit.niso.org/contributor-roles/writing-review-editing/"/></contrib>
</contrib-group>
<aff id="aff1"><label><sup>1</sup></label><institution>Laboratory of Sport Medicine, Department of Physical Education and Sport Science, Aristotle University of Thessaloniki, Thessaloniki</institution>, <country>Greece</country></aff>
<aff id="aff2"><label><sup>2</sup></label><institution>Lifestyle, Exercise and Nutritional Improvement (LENI) Research Group, Department of Nursing and Midwifery</institution>, <institution>Sheffield Hallam University</institution>, <addr-line>Sheffield</addr-line>, <country>United Kingdom</country></aff>
<aff id="aff3"><label><sup>3</sup></label><institution>Laboratory of Management of Sports Recreation and Tourism, Department of Physical Education and Sport Science, Aristotle University of Thessaloniki, Thessaloniki</institution>, <country>Greece</country></aff>
<aff id="aff4"><label><sup>4</sup></label><institution>Department of Physical Education, Sports Sciences Frederick University</institution>, <addr-line>Nicosia</addr-line>, <country>Cyprus</country></aff>
<author-notes>
<fn fn-type="edited-by"><p><bold>Edited by:</bold> Tatiana Kuznetsova, KU Leuven, Belgium</p></fn>
<fn fn-type="edited-by"><p><bold>Reviewed by:</bold> Nicholas Cauwenberghs, KU Leuven, Belgium</p>
<p>Roxana Oana Darabont, Carol Davila University of Medicine and Pharmacy, Romania</p></fn>
<corresp id="cor1"><label>&#x002A;</label><bold>Correspondence:</bold> E. Kouidi <email>kouidi@phed.auth.gr</email></corresp>
</author-notes>
<pub-date pub-type="epub"><day>05</day><month>06</month><year>2024</year></pub-date>
<pub-date pub-type="collection"><year>2024</year></pub-date>
<volume>11</volume><elocation-id>1410616</elocation-id>
<history>
<date date-type="received"><day>01</day><month>04</month><year>2024</year></date>
<date date-type="accepted"><day>15</day><month>05</month><year>2024</year></date>
</history>
<permissions>
<copyright-statement>&#x00A9; 2024 Mitropoulos, Anifanti, Koukouvou, Ntovoli, Alexandris and Kouidi.</copyright-statement>
<copyright-year>2024</copyright-year><copyright-holder>Mitropoulos, Anifanti, Koukouvou, Ntovoli, Alexandris and Kouidi</copyright-holder><license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by/4.0/">
<p>This is an open-access article distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License (CC BY)</ext-link>. The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.</p></license>
</permissions>
<abstract><sec><title>Background</title>
<p>Exercise-based cardiac rehabilitation (CR) is a non-pharmacological multidisciplinary programme for individuals after myocardial infarction (MI) that offers multiple health benefits. One of the greatest barriers to CR participation is the travel distance to the rehabilitation centre. Remotely monitored CR appears to be at least as effective in improving cardiovascular risk factors and exercise capacity as traditional centre-based CR. Nevertheless, the efficacy of remotely monitored CR in individuals with a recent MI has yet to be examined.</p>
</sec><sec><title>Methods</title>
<p>A total of 30 individuals (8 women, 22 men) after a recent (i.e., &#x003C;4 weeks) MI were randomly allocated into two groups (online home-based and gym-based groups). Both groups underwent a 26-week CR programme three times per week. All patients performed baseline and 24-week follow-up measurements where peak oxygen uptake (VO<sub>2peak</sub>), mean daily steps, distance, and calories were assessed.</p>
</sec><sec><title>Results</title>
<p>The online group showed an improvement in mean daily steps (<italic>p</italic>&#x2009;&#x003C;&#x2009;0.05) and mean daily distance (<italic>p</italic>&#x2009;&#x003C;&#x2009;0.05) at 24 weeks compared to the gym-based group. The paired-sample <italic>t</italic>-test showed that all the assessed variables were statistically (<italic>p</italic>&#x2009;&#x003C;&#x2009;0.001) improved for both groups at 24 weeks. Pearson&#x0027;s <italic>r</italic> demonstrated positive correlations between VO<sub>2peak</sub> and mean daily distance (<italic>r</italic>&#x2009;&#x003D;&#x2009;0.375), and negative correlations between VO<sub>2peak</sub> and muscle (<italic>r</italic>&#x2009;&#x003D;&#x2009;&#x2212;0.523) and fat masses (<italic>r</italic>&#x2009;&#x003D;&#x2009;&#x2212;0.460). There were no exercise-induced adverse events during the study.</p>
</sec><sec><title>Conclusion</title>
<p>Our findings might indicate that a real-time online supervised CR exercise programme using wearable technology to monitor the haemodynamic responses in post-MI patients is equally effective as a gym-based exercise programme.</p>
</sec>
</abstract>
<kwd-group>
<kwd>online exercise</kwd>
<kwd>home-based exercise</kwd>
<kwd>coronary heart disease</kwd>
<kwd>myocardial infarction</kwd>
<kwd>cardiac rehabilitation</kwd>
</kwd-group><contract-num rid="cn001">&#x00A0;</contract-num><contract-num rid="cn002">&#x00A0;</contract-num><contract-num rid="cn003">&#x00A0;</contract-num><contract-sponsor id="cn001">Operational Programme &#x201C;Central Macedonia&#x201D; of the PA 2021&#x2013;2027 Innovative Investment Plans</contract-sponsor><contract-sponsor id="cn002">Greek State and the EU</contract-sponsor><contract-sponsor id="cn003">ERD</contract-sponsor><counts>
<fig-count count="2"/>
<table-count count="2"/><equation-count count="0"/><ref-count count="46"/><page-count count="10"/><word-count count="0"/></counts><custom-meta-wrap><custom-meta><meta-name>section-at-acceptance</meta-name><meta-value>Precision Cardiology</meta-value></custom-meta></custom-meta-wrap>
</article-meta>
</front>
<body><sec id="s1" sec-type="intro"><title>Introduction</title>
<p>Myocardial infarction (MI) is a life-threatening coronary event (<xref ref-type="bibr" rid="B1">1</xref>) and the most severe clinical manifestation of coronary artery disease (CAD) (<xref ref-type="bibr" rid="B2">2</xref>). In 2020, cardiovascular disease (CVD) globally accounted for 19.05 million deaths, which corresponded to an increase of 18.71&#x0025; from 2010 (<xref ref-type="bibr" rid="B3">3</xref>). The 2020 Hellenic Statistical data revealed that nearly 35&#x0025; of all deaths in Greece were attributed to CVD, such as stroke and ischaemic heart diseases (<xref ref-type="bibr" rid="B4">4</xref>). In the Greek population, 8 out of 10 adults have at least one major modifiable risk factor (e.g., diabetes, hypercholesterolemia, hypertension, smoking, and physical inactivity) for CVD (<xref ref-type="bibr" rid="B5">5</xref>). The overall age-adjusted prevalence of MI in the Greek population was found to be 3.6&#x0025; (<xref ref-type="bibr" rid="B5">5</xref>). It was estimated that in adults, approximately 8.7&#x0025; of all-cause mortality was attributed to a physical activity (PA) level lower than the recommended levels (<xref ref-type="bibr" rid="B3">3</xref>).</p>
<p>Exercise-based cardiac rehabilitation (CR) is a non-pharmacological, multidisciplinary, programme for individuals after MI that offers multiple health benefits. For example, CR is able to improve cardiorespiratory fitness (CRF), quality of life (QoL), and exercise capacity, as well as reduce morbidity and mortality (<xref ref-type="bibr" rid="B6">6</xref>). More specifically, a large research clinical trial (<italic>n</italic>&#x2009;&#x003D;&#x2009;359 people with acute MI) demonstrated that a 6-week hospital- or home-based CR programme significantly improved the resting heart rate (HR), peak oxygen uptake (VO<sub>2peak</sub>), total exercise duration, and metabolic equivalents regardless of obesity (<xref ref-type="bibr" rid="B7">7</xref>).</p>
<p>The global consensus recommendations for CR programmes after MI indicate that these programmes should be offered to all affected patients (<xref ref-type="bibr" rid="B8">8</xref>). Despite the proven efficacy of the CR programmes and the international consensus for their implementation, participation, and adherence rates to these programmes are low. A recently published study in Greece demonstrated that the greatest barriers seem to be distance from the rehabilitation centre, costs, lack of information about CR, and the fact that some patients perform exercise at home (<xref ref-type="bibr" rid="B9">9</xref>). To overcome the barriers of distance and related travel costs, a well-structured, safe, and feasible cardiac telerehabilitation programme is warranted.</p>
<p>Recent evidence indicates the potential for remotely monitored CR for people with cardiac conditions (<xref ref-type="bibr" rid="B10">10</xref>). That is, remotely monitored CR appears to be at least as effective in improving cardiovascular risk factors and exercise capacity as traditional centre-based cardiac rehabilitation (<xref ref-type="bibr" rid="B11">11</xref>). Several studies have utilised wearable sensors [e.g., HR and electrocardiogram (ECG) monitors] to remotely monitor the intensity and safety of the exercise protocol in people with cardiac conditions (<xref ref-type="bibr" rid="B10">10</xref>). Nevertheless, the efficacy of a remotely monitored CR in people with recent MI has yet to be examined.</p>
<p>The aim of this randomised controlled trial was to compare a real-time home-based cardiac telerehabilitation programme monitored by wearable devices in people with recent MI against a traditional gym-based cardiac rehabilitation programme. To our knowledge, this is the first clinical trial to perform CR utilising both telemonitoring and real-time online tele-coaching in people with recent MI. It was hypothesised that the combination of telemonitoring (i.e., wearable devices) and tele-coaching (i.e., a real-time online CR instructor) will allow us to safely balance the intensities of home- and gym-based CR exercise programmes.</p>
</sec>
<sec id="s2" sec-type="methods"><title>Methods</title>
<sec id="s2a"><title>Study design</title>
<p>This was a single-centre, pragmatic, double-blinded (e.g., assessor pre- and post-measurements, independent statistician), two-arm randomised controlled trial conducted in Thessaloniki, Greece. We recruited 30 people (8 women, 22 men) after a recent (i.e., &#x003C;4 weeks) MI with a stable clinical status. The exclusion criteria consisted of the following: (1) unstable angina; (2) acute heart failure (HF); (3) severe heart failure with left ventricle ejection fraction (LVEF) &#x003C;30&#x0025;; (4) malignant ventricular arrhythmias; (5) uncontrolled arterial hypertension; (6) musculoskeletal or neurological impairments; and (7) psychological or cognitive disorders that may affect their participation in the exercise programmes. Eligible participants were recruited from the Cardiology Clinics of the University and private Hospitals of Thessaloniki, Greece, and from private physicians&#x2019; practices. All patients provided written consent to participate. The Research Ethics Committee of the School of Physical Education and Sport Science of Thessaloniki (Greece) approved the study protocol, and the study complied with the Declaration of Helsinki. The study has also been registered on ClinicalTrial.gov (ID: NCT06071273).</p>
</sec>
<sec id="s2b"><title>Patient and public involvement</title>
<p>Although the current study explores the effectiveness of an online CR programme for post-MI patients, we did involve post-MI patients in the design of our methods and their preferences for exercise modalities. That is, our baseline and follow-up assessment protocol (i.e., peak oxygen uptake test) has been shaped to include the minimum core assessments that will provide a response concerning the effectiveness of our protocol and that will not increase the clinical burden (i.e., prolonged assessments) for our participants based on their preferences.</p>
<p>After the baseline assessment, participants were randomly allocated into two groups: online home-based (online monitored, home-based exercise group; <italic>n</italic>&#x2009;&#x003D;&#x2009;15) or gym-based (in-person attendance at community-based health clubs exercise group; <italic>n</italic>&#x2009;&#x003D;&#x2009;15). The exercise groups followed a similar structure and exercise protocol for 6&#x2005;months. A Consolidated Standards of Reporting Trials (CONSORT) flow diagram is shown in <xref ref-type="fig" rid="F1">Figure&#x00A0;1</xref>. After the baseline assessment, each patient was provided with a watch accelerometer recorder for 7 days. All pre- and post-intervention tests were performed at the same time of day (i.e., in the morning) to minimise intra-day variability by the same assessors who were blinded to group allocation.</p>
<fig id="F1" position="float"><label>Figure 1</label>
<caption><p>Individualised Scanwatch report.</p></caption>
<graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="fcvm-11-1410616-g001.tif"/>
</fig>
<sec id="s2b1"><title>Randomisation</title>
<p>To ensure allocation concealment, participants were randomly allocated (stratified randomisation) by an independent statistician blinded to the study&#x0027;s procedures into two groups using nQuery (GraphPad Software, DBA Statistical Solutions, Boston, MA, USA) software after the baseline assessment. The stratified randomisation was based on four variables: sex (i.e., male/female), number of comorbidities (e.g., hypertension), echocardiography (i.e., LVEF), and CRF (i.e., VO<sub>2peak</sub> ml/kg/min) tests. The allocated group was announced to both the principal investigator and each participant only to prevent selection bias.</p>
</sec>
</sec>
</sec>
<sec id="s3"><title>Study outcomes</title>
<sec id="s3a"><title>Anthropometrics</title>
<p>The participant&#x0027;s height was measured using a Hite-Rite Precision Mechanical Stadiometer. Body weight (kg), body mass index (BMI), fat mass (kg), and lean body mass (kg) were assessed at baseline and 6-month follow-up using a bio-electrical impedance analysis electrical scale (Bodystat Quadscan 4000 Touch, Bodystat Limited, Isle of Man, British Isles).</p>
</sec>
<sec id="s3b"><title>Peak oxygen uptake test on a treadmill ergometer</title>
<p>During the cardiopulmonary tests, gas exchange was collected and analysed using an online breath-by-breath analysis system (Ultima&#x2122; CPX Series; Medical Graphics Corporation, Saint Paul, MN, USA). HR and ECG were continuously monitored using a Polar HR monitor (Polar FS1, Polar Electro, Kempele, Finland) and a 12-lead ECG device (CardioSoft V6.73; GE Healthcare, Chicago, IL, USA). Blood pressure (BP) was assessed during the third minute of each stage using a sphygmomanometer. Ratings of perceived exertion (RPE) were recorded during the last 10&#x2005;s of each minute of the exercise test until volitional exhaustion using the Borg scale of 6&#x2013;20 points. Treadmill ergometer speed and inclination and test duration were also recorded. VO<sub>2peak</sub> was defined as the average oxygen consumption that was recorded from expiratory samples during the final 30&#x2005;s of exercise. The respiratory exchange ratio (RER) was &#x2265;1.10.</p>
</sec>
<sec id="s3c"><title>Echocardiography</title>
<p>Echocardiography was assessed only at baseline, as this measurement was mainly used to explore the echocardiographic characteristics of our participants and ascertain balanced group randomisation. The echocardiographic assessment was performed using a Vivid S70 (GE Healthcare, Chicago, IL, USA) equipped with an M5S phased-array transducer. All examinations were stored in EchoPAC version 204 and analysed according to the guidelines of the European Association of Cardiovascular Imaging and the American Society of Echocardiography. The modified biplane Simpson method was used to assess the size and the systolic function of the left ventricle (LV). LVEF, end-diastolic volume, and end systolic volume of the LV were measured. A wall motion evaluation for segmental wall motion abnormalities was performed. The maximum volume of the left atrium was also measured. The diastolic function and LV filling pressure were assessed using early diastolic transmitral flow velocity, late diastolic transmitral flow velocity, and their ratio. Tissue Doppler imaging was used to display myocardial velocities in the lateral and septal basal regions and to calculate the average E/E&#x2019; ratio as an index of left ventricular filling pressure.</p>
</sec>
<sec id="s3d"><title>Physical activity assessment</title>
<p>After the baseline and 6-month follow-up assessments, all patients were provided with a watch accelerometer recorder (Scanwatch, Withings, Issy-les-Moulineaux, France) for 7 consecutive days. Patients were requested to wear the watch accelerometer for 24&#x2005;h/day except during bathing. The data were considered valid with a minimum of four weekdays and one weekend day of recordings for at least 19&#x2005;h per day, which constitutes 80&#x0025; of the 24&#x2005;h. All data were uploaded to the online platform and stored in each patient&#x0027;s electronic health record. The mean daily steps, distance, and calories for each patient were estimated.</p>
</sec>
<sec id="s3e"><title>Exercise programme</title>
<sec id="s3e1"><title>Design of the interventions</title>
<sec id="s3e1a"><title>Home-based group</title>
<p>During the online real-time exercise session, all the haemodynamic responses and readings were continuously transferred live via the mobile application to the health instructor and cardiologist who were delivering and monitoring the session, respectively. The online session was delivered in real-time via the Zoom (<ext-link ext-link-type="uri" xlink:href="https://zoom.us">https://zoom.us</ext-link>) web-based platform. Beyond the haemodynamic responses, participants were requested to provide the RPE levels at regular intervals during the exercise session.</p>
</sec>
</sec>
<sec id="s3e2"><title>Telemonitoring and wearable devices</title>
<p>The home-based group was provided with the following equipment: (1) a smart watch (Scanwatch; Withings, Issy-les-Moulineaux, France) with ECG and HR readings; (2) an oximeter assessing the saturation of oxygen; (3) an automated BP monitor; and (4) an electric body scale. Scanwatch is a validated analogue watch that allows 30&#x2005;s single-lead ECG recordings and performs spot measurements of peripheral oxygen saturation (SpO<sub>2</sub>). HR is also measured intermittently, while physical activity (steps) is measured continuously. Scanwatch uses the following three types of sensors: (1) dry electrodes (ECG); (2) optical sensors (SpO<sub>2</sub> and pulse rate); and (3) accelerometer (physical activity). Individualised reports for daily calories, steps, and distance were also recorded via Scanwatch (<xref ref-type="fig" rid="F1">Figure&#x00A0;1</xref>). Furthermore, an online web platform was created where the cardiologists were able to log in and monitor the overall haemodynamic responses of the patients both during exercise in real-time and at rest.</p>
<sec id="s3e2a"><title>Gym-based group</title>
<p>The gym-based group was requested to attend a community-based health club near their residence. The gym-based group followed an identical exercise training programme to the home-based group under the instruction and supervision of a physical education teacher experienced in cardiac rehabilitation, but without monitoring the haemodynamic parameters during the exercise sessions. The Borg RPE scale was used to assess the patients&#x2019; perceptions of their effort and exertion. The patients in both groups had to attend at least 80&#x0025; of the exercise sessions offered to be included in the analysis.</p>
</sec>
</sec>
<sec id="s3e3"><title>Intensity and volume of the aerobic protocol</title>
<p>Based on the joint position statement of the European Association for Cardiovascular Prevention and Rehabilitation, the American Association of Cardiovascular and Pulmonary Rehabilitation, and the Canadian Association of Cardiac Rehabilitation (<xref ref-type="bibr" rid="B12">12</xref>), our exercise protocol was appropriately structured to fit the cardiometabolic requirements for cardiac patients. After a cardiopulmonary exercise test (CPET) on a treadmill ergometer, including VO<sub>2peak</sub>, ECG, BP, and HR outcomes, we devised an individualised low- to moderate-intensity aerobic protocol based on the patient&#x0027;s physiological responses [i.e., ventilatory thresholds (VTs) 1 and 2, ECG, BP, and HR<sub>peak</sub>] during the CPET.</p>
<p>Overall, the goal of exercise training for cardiac patients is to reach approximately 1,500&#x2005;kcal/week (<xref ref-type="bibr" rid="B13">13</xref>), which corresponds roughly to moderate-to-vigorous intensity exercise 6&#x2005;days/week. However, this level is difficult to attain by some patients, especially for those in the early post-hospitalisation phase (i.e., people with CAD after a recent MI). Early post-hospitalisation exercise training involves an attainable training dose of 20&#x2013;30&#x2005;min per session for 3&#x2013;4 days per week (<xref ref-type="bibr" rid="B12">12</xref>). In addition, considering the lower fitness-lower training stimulus intensity principle, intensities even much lower than those corresponding to VT1 should be effective in cardiac patients with a markedly reduced exercise capacity (i.e., early post-hospitalisation patients). Aerobic training intensities as low as 40&#x0025; VO<sub>2peak</sub> (corresponding to approximately 25&#x0025; VO<sub>2</sub>R) have demonstrated to be effective in patients with chronic HF with significantly reduced pre-training peak VO<sub>2</sub> (<xref ref-type="bibr" rid="B14">14</xref>). Therefore, based on the above, our exercise protocol for our study participants who were considered in the early post-hospitalisation phase (i.e., recent MI) was to perform three non-consecutive sessions per week, with the duration of the aerobic protocol (i.e., aerobic music workout) at 30&#x2005;min and the intensity as moderate (i.e., VT1, which marks the limit between the slight and moderate intensity of exercise).</p>
<p>The training principle of progression (<xref ref-type="bibr" rid="B15">15</xref>) is delineated as the gradual and systematic increases in the overall training dose (i.e., frequency, intensity, and/or volume) to maintain overload, thus inducing further training adaptations. In our study, the volume of aerobic exercise could not be altered due to the overall duration of each exercise session (i.e., 1&#x2005;h) to assure the pragmatic conditions of our exercise programme. Therefore, to ensure the training progression of the aerobic protocol for each of our participants, the intensity was adapted based on the participant&#x0027;s RPE responses (for both groups) and HR recordings (for the home-based group).</p>
</sec>
<sec id="s3e4"><title>Resistance training protocol</title>
<p>Resistance training (RT) combined with aerobic exercise is more beneficial than aerobic exercise alone for coronary heart disease (<xref ref-type="bibr" rid="B16">16</xref>). RT can effectively improve exercise capacity and a patient&#x0027;s QoL compared with usual care (<xref ref-type="bibr" rid="B16">16</xref>). Sarcopenia (i.e., loss of skeletal muscle strength, mass, and functionality) is commonly reported in CVD populations, such as in individuals with HF and CAD (<xref ref-type="bibr" rid="B17">17</xref>). The loss of muscle mass and strength negatively affects QoL and is an independent predictor of mortality in people with CVD (<xref ref-type="bibr" rid="B18">18</xref>). RT is able to induce musculoskeletal improvements, including muscle strength, power, hypertrophy, and muscle endurance.</p>
<p>Considering the American College of Sports Medicine&#x0027;s guidelines for cardiac patients (<xref ref-type="bibr" rid="B13">13</xref>) and a recent review of the available literature with respect to RT in cardiac rehabilitation (<xref ref-type="bibr" rid="B19">19</xref>), we devised our RT protocol (similar for both groups), which consisted of four main muscle group exercises (e.g., chest press, low row, lateral raising of the arms in an upright position, and chair-based bodyweight squat) that were performed using resistance bands (TheraBand, Akron, OH, USA), 1&#x2013;3 sets per exercise, 90&#x2005;s rest between sets, and 8&#x2013;10 repetitions for each set, corresponding to an intensity of 13&#x2013;15 on the RPE scale (scale of 6&#x2013;20 points). The total RT duration was approximately 15&#x2005;min.</p>
<p>Optimal progression models for hypertrophy, strength, power, and muscular endurance have not yet been delineated in people with cardiac conditions (<xref ref-type="bibr" rid="B19">19</xref>). In our study, to account for the training musculoskeletal adaptations to RT, we continuously monitored the RPE responses of our participants during each resistance exercise. Following consistent (&#x003E;3 consecutive times) RPE responses that were below the lowest point of the target range (i.e., &#x003C;13), the intensity was increasingly adjusted by altering either the participant&#x0027;s distance from the resistance band or the intensity of the resistance band (i.e., changing the colour of the band corresponding to a higher intensity).</p>
</sec>
<sec id="s3e5"><title>Balance and flexibility training protocol</title>
<p>Both groups performed identical balance and flexibility training. More specifically, the balance training consisted of the following two balance exercises (<xref ref-type="bibr" rid="B20">20</xref>): (1) walking heel-to-toe (3 sets of 20 steps per set); and (2) standing on one foot (10&#x2013;15 sets of 8&#x2005;s for each leg). Flexibility training (<xref ref-type="bibr" rid="B21">21</xref>) consisted of the following stretching exercises: (1) torso stretch, (2) torso twist, (3) neck stretch, (4) quadriceps stretch, (5) hamstring stretch, (6) calf stretch, (7) shoulder stretch, and (8) chest stretch. Each stretch had a duration of 15&#x2013;30&#x2005;s, three to five times per side.</p>
</sec>
</sec>
<sec id="s3f"><title>Statistical analysis</title>
<p>Data analysis was performed using SPSS software version 23 (IBM Corp., Armonk, NY, USA) and is presented as mean&#x2009;&#x00B1;&#x2009;SD. Normal distribution of the data and homogeneity of variances were tested using the Shapiro&#x2013;Wilk and Levene&#x0027;s tests, respectively. The comparison of the anthropometric, CRF, and physical activity variables between and within the two groups (i.e., pre- and post-differences within the same group) was carried out through independent and paired-sample <italic>t</italic>-tests; chi-square tests were also used to identify the differences between the two groups. Pearson&#x0027;s correlation coefficient was performed between all variables to assess any linear correlations in our data. Statistical significance was set at <italic>p</italic>&#x2009;&#x2264;&#x2009;0.05.</p>
</sec>
</sec>
<sec id="s4" sec-type="results"><title>Results</title>
<p>A total of 53 patients with CAD after a recent MI were recruited at baseline; 6 patients did not meet the inclusion criteria and 11 declined to participate in the study. The remaining 36 patients were randomly assigned to two equally sized groups. However, three patients from each group withdrew from the study. The flowchart of participants was based on recommendations from CONSORT and is presented in <xref ref-type="fig" rid="F2">Figure&#x00A0;2</xref>. There was no statistically significant difference between the two groups&#x2019; demographic and clinical characteristics (<xref ref-type="table" rid="T1">Table&#x00A0;1</xref>).</p>
<fig id="F2" position="float"><label>Figure 2</label>
<caption><p>CONSORT flowchart.</p></caption>
<graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="fcvm-11-1410616-g002.tif"/>
</fig>
<table-wrap id="T1" position="float"><label>Table 1</label>
<caption><p>Participants&#x2019; demographic and clinical characteristics.</p></caption>
<table frame="hsides" rules="groups">
<colgroup>
<col align="left"/>
<col align="center"/>
<col align="center"/>
<col align="center"/>
<col align="center"/>
</colgroup>
<thead>
<tr>
<th valign="top" align="left"/>
<th valign="top" align="center">Online group (<italic>n</italic>&#x2009;&#x003D;&#x2009;15)</th>
<th valign="top" align="center">Gym-based group (<italic>n</italic>&#x2009;&#x003D;&#x2009;15)</th>
<th valign="top" align="center">Total (<italic>n</italic>&#x2009;&#x003D;&#x2009;30)</th>
<th valign="top" align="center"><italic>p</italic>-values</th>
</tr>
</thead>
<tbody>
<tr>
<td valign="top" align="left">Age (years)</td>
<td valign="top" align="center">54.1&#x2009;&#x00B1;&#x2009;8.5</td>
<td valign="top" align="center">53.5&#x2009;&#x00B1;&#x2009;6.6</td>
<td valign="top" align="center">53.8&#x2009;&#x00B1;&#x2009;7.5</td>
<td valign="top" align="center">0.85</td>
</tr>
<tr>
<td valign="top" align="left">Sex (male &#x0025;)</td>
<td valign="top" align="center">73</td>
<td valign="top" align="center">73</td>
<td valign="top" align="center">73</td>
<td valign="top" align="center"/>
</tr>
<tr>
<td valign="top" align="left">Body weight (kg)</td>
<td valign="top" align="center">88.5&#x2009;&#x00B1;&#x2009;18.1</td>
<td valign="top" align="center">87.5&#x2009;&#x00B1;&#x2009;12.1</td>
<td valign="top" align="center">88.0&#x2009;&#x00B1;&#x2009;15.1</td>
<td valign="top" align="center">0.87</td>
</tr>
<tr>
<td valign="top" align="left">Height (cm)</td>
<td valign="top" align="center">176.5&#x2009;&#x00B1;&#x2009;7.6</td>
<td valign="top" align="center">174.6&#x2009;&#x00B1;&#x2009;7.5</td>
<td valign="top" align="center">175.6&#x2009;&#x00B1;&#x2009;7.5</td>
<td valign="top" align="center">0.49</td>
</tr>
<tr>
<td valign="top" align="left">BMI (kg/m<sup>2</sup>)</td>
<td valign="top" align="center">28.1&#x2009;&#x00B1;&#x2009;3.8</td>
<td valign="top" align="center">28.7&#x2009;&#x00B1;&#x2009;3.0</td>
<td valign="top" align="center">28.4&#x2009;&#x00B1;&#x2009;3.4</td>
<td valign="top" align="center">0.67</td>
</tr>
<tr>
<td valign="top" align="left">BSA</td>
<td valign="top" align="center">2.0&#x2009;&#x00B1;&#x2009;0.2</td>
<td valign="top" align="center">2.0&#x2009;&#x00B1;&#x2009;0.2</td>
<td valign="top" align="center">2.0&#x2009;&#x00B1;&#x2009;0.2</td>
<td valign="top" align="center">0.66</td>
</tr>
<tr>
<td valign="top" align="left">LVEF (&#x0025;)</td>
<td valign="top" align="center">49.5&#x2009;&#x00B1;&#x2009;11.5</td>
<td valign="top" align="center">51.1&#x2009;&#x00B1;&#x2009;9.7</td>
<td valign="top" align="center">50.3&#x2009;&#x00B1;&#x2009;10.5</td>
<td valign="top" align="center">0.67</td>
</tr>
<tr>
<td valign="top" align="left">HR rest (bpm)</td>
<td valign="top" align="center">73&#x2009;&#x00B1;&#x2009;16</td>
<td valign="top" align="center">70&#x2009;&#x00B1;&#x2009;18</td>
<td valign="top" align="center">72&#x2009;&#x00B1;&#x2009;14</td>
<td valign="top" align="center">0.56</td>
</tr>
<tr>
<td valign="top" align="left">SBP rest (mmHg)</td>
<td valign="top" align="center">113.57&#x2009;&#x00B1;&#x2009;18.23</td>
<td valign="top" align="center">121.74&#x2009;&#x00B1;&#x2009;15.82</td>
<td valign="top" align="center">117&#x2009;&#x00B1;&#x2009;14</td>
<td valign="top" align="center">0.13</td>
</tr>
<tr>
<td valign="top" align="left">DBP rest (mmHg)</td>
<td valign="top" align="center">72.43&#x2009;&#x00B1;&#x2009;12.04</td>
<td valign="top" align="center">76.21&#x2009;&#x00B1;&#x2009;18.61</td>
<td valign="top" align="center">74&#x2009;&#x00B1;&#x2009;12</td>
<td valign="top" align="center">0.38</td>
</tr>
<tr>
<td valign="top" align="left" colspan="5">Risk factors</td>
</tr>
<tr>
<td valign="top" align="left">Hypertension, <italic>n</italic> (&#x0025;)</td>
<td valign="top" align="center">5 (33.3)</td>
<td valign="top" align="center">4 (26.7)</td>
<td valign="top" align="center"/>
<td valign="top" align="center">0.61</td>
</tr>
<tr>
<td valign="top" align="left">Diabetes mellitus, <italic>n</italic> (&#x0025;)</td>
<td valign="top" align="center">2 (13.3)</td>
<td valign="top" align="center">3 (20)</td>
<td valign="top" align="center"/>
<td valign="top" align="center">0.63</td>
</tr>
<tr>
<td valign="top" align="left">Dyslipidaemia, <italic>n</italic> (&#x0025;)</td>
<td valign="top" align="center">5 (33.3)</td>
<td valign="top" align="center">7 (46.7)</td>
<td valign="top" align="center"/>
<td valign="top" align="center">0.47</td>
</tr>
<tr>
<td valign="top" align="left">Smoking, <italic>n</italic> (&#x0025;)</td>
<td valign="top" align="center">8 (53.3)</td>
<td valign="top" align="center">5 (33.3)</td>
<td valign="top" align="center"/>
<td valign="top" align="center">0.27</td>
</tr>
<tr>
<td valign="top" align="left">Family history, <italic>n</italic> (&#x0025;)</td>
<td valign="top" align="center">4 (26.7)</td>
<td valign="top" align="center">6 (40)</td>
<td valign="top" align="center"/>
<td valign="top" align="center">0.44</td>
</tr>
<tr>
<td valign="top" align="left" colspan="5">Clinical</td>
</tr>
<tr>
<td valign="top" align="left">Time after MI (months)</td>
<td valign="top" align="center">3.5</td>
<td valign="top" align="center">3.2</td>
<td valign="top" align="center"/>
<td valign="top" align="center"/>
</tr>
<tr>
<td valign="top" align="left">STEMI, <italic>n</italic> (&#x0025;)</td>
<td valign="top" align="center">12 (80)</td>
<td valign="top" align="center">10 (66.7)</td>
<td valign="top" align="center"/>
<td valign="top" align="center">0.41</td>
</tr>
<tr>
<td valign="top" align="left">Anterior, <italic>n</italic> (&#x0025;)</td>
<td valign="top" align="center">7 (46.7)</td>
<td valign="top" align="center">6 (40)</td>
<td valign="top" align="center"/>
<td valign="top" align="center">0.71</td>
</tr>
<tr>
<td valign="top" align="left">Inferior, <italic>n</italic> (&#x0025;)</td>
<td valign="top" align="center">5 (33.3)</td>
<td valign="top" align="center">4 (26.7)</td>
<td valign="top" align="center"/>
<td valign="top" align="center">0.69</td>
</tr>
<tr>
<td valign="top" align="left">NSTEMI, <italic>n</italic> (&#x0025;)</td>
<td valign="top" align="center">3 (20)</td>
<td valign="top" align="center">5 (33.3)</td>
<td valign="top" align="center"/>
<td valign="top" align="center">0.41</td>
</tr>
<tr>
<td valign="top" align="left">PCI, <italic>n</italic> (&#x0025;)</td>
<td valign="top" align="center">14 (93.3)</td>
<td valign="top" align="center">13 (86.7)</td>
<td valign="top" align="center"/>
<td valign="top" align="center">0.54</td>
</tr>
<tr>
<td valign="top" align="left">CABG, <italic>n</italic> (&#x0025;)</td>
<td valign="top" align="center">1 (6.7)</td>
<td valign="top" align="center">2 (13.3)</td>
<td valign="top" align="center"/>
<td valign="top" align="center">0.54</td>
</tr>
<tr>
<td valign="top" align="left" colspan="5">Medications</td>
</tr>
<tr>
<td valign="top" align="left">Beta blockers, <italic>n</italic> (&#x0025;)</td>
<td valign="top" align="center">12 (80)</td>
<td valign="top" align="center">13 (86.7)</td>
<td valign="top" align="center"/>
<td valign="top" align="center">0.62</td>
</tr>
<tr>
<td valign="top" align="left">Antiplatelet, <italic>n</italic> (&#x0025;)</td>
<td valign="top" align="center">15 (100)</td>
<td valign="top" align="center">15 (100)</td>
<td valign="top" align="center"/>
<td valign="top" align="center">1.0</td>
</tr>
<tr>
<td valign="top" align="left">ACE inhibitors, <italic>n</italic> (&#x0025;)</td>
<td valign="top" align="center">13 (86.7)</td>
<td valign="top" align="center">11 (73.3)</td>
<td valign="top" align="center"/>
<td valign="top" align="center">0.36</td>
</tr>
<tr>
<td valign="top" align="left">Statin, <italic>n</italic> (&#x0025;)</td>
<td valign="top" align="center">14 (93.3)</td>
<td valign="top" align="center">14 (93.3)</td>
<td valign="top" align="center"/>
<td valign="top" align="center">1.00</td>
</tr>
<tr>
<td valign="top" align="left">Hypoglycaemic, <italic>n</italic> (&#x0025;)</td>
<td valign="top" align="center">2 (13.3)</td>
<td valign="top" align="center">3 (20)</td>
<td valign="top" align="center"/>
<td valign="top" align="center">0.62</td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<fn id="table-fn1"><p>CABG, coronary artery bypass graft; DBP, diastolic blood pressure; PBF, percentage of body fat; STEMI, ST-elevation myocardial infarction; NSTEMI, non-ST elevation myocardial infarction; PCI, percutaneous coronary intervention; SBP, systolic blood pressure.</p></fn>
</table-wrap-foot>
</table-wrap>
<p>High compliance was reported concerning the watch accelerometer recorder since all participants met the valid wear time criteria (i.e., &#x2265;80&#x0025;). There were no exercise-induced adverse events during the study. Anthropometric and echocardiographic characteristics, including HR and blood pressure assessments, did not demonstrate statistically significant differences between the groups (<xref ref-type="table" rid="T1">Table&#x00A0;1</xref>).</p>
<p>The independent <italic>t</italic>-test revealed that at baseline, the VO<sub>2peak</sub> exercise time (<italic>p</italic>&#x2009;&#x003C;&#x2009;0.05) for the gym-based group was of longer duration compared to the online group (<xref ref-type="table" rid="T2">Table&#x00A0;2</xref>). The online group showed statistically significant improvements in mean daily steps (<italic>p</italic>&#x2009;&#x003C;&#x2009;0.05) and mean daily distance (<italic>p</italic>&#x2009;&#x003C;&#x2009;0.05) at 24 weeks compared to the gym-based group (<xref ref-type="table" rid="T2">Table&#x00A0;2</xref>). The remaining variables did not show any statistically significant differences in between-group comparisons.</p>
<table-wrap id="T2" position="float"><label>Table 2</label>
<caption><p>Within-group comparison at baseline and 24 weeks.</p></caption>
<table frame="hsides" rules="groups">
<colgroup>
<col align="left"/>
<col align="center"/>
<col align="center"/>
<col align="center"/>
<col align="center"/>
</colgroup>
<thead>
<tr>
<th valign="top" align="left" rowspan="2"/>
<th valign="top" align="center" colspan="2">Online group (<italic>n</italic>&#x2009;&#x003D;&#x2009;15)</th>
<th valign="top" align="center" colspan="2">Gym-based group (<italic>n</italic>&#x2009;&#x003D;&#x2009;15)</th>
</tr>
<tr>
<th valign="top" align="center">Baseline</th>
<th valign="top" align="center">24 weeks</th>
<th valign="top" align="center">Baseline</th>
<th valign="top" align="center">24 weeks</th>
</tr>
</thead>
<tbody>
<tr>
<td valign="top" align="left">VO<sub>2peak</sub> (ml/kg/min)</td>
<td valign="top" align="center">27.2&#x2009;&#x00B1;&#x2009;3.4</td>
<td valign="top" align="center">29.4&#x2009;&#x00B1;&#x2009;3.5<xref ref-type="table-fn" rid="table-fn2">&#x002A;</xref></td>
<td valign="top" align="center">26.7&#x2009;&#x00B1;&#x2009;2.6</td>
<td valign="top" align="center">29.5&#x2009;&#x00B1;&#x2009;2.8<xref ref-type="table-fn" rid="table-fn2">&#x002A;</xref></td>
</tr>
<tr>
<td valign="top" align="left">Predicted VO<sub>2peak</sub> (&#x0025;)</td>
<td valign="top" align="center">85&#x2009;&#x00B1;&#x2009;12</td>
<td valign="top" align="center">92&#x2009;&#x00B1;&#x2009;13<xref ref-type="table-fn" rid="table-fn2">&#x002A;</xref></td>
<td valign="top" align="center">84&#x2009;&#x00B1;&#x2009;8</td>
<td valign="top" align="center">92&#x2009;&#x00B1;&#x2009;10<xref ref-type="table-fn" rid="table-fn2">&#x002A;</xref></td>
</tr>
<tr>
<td valign="top" align="left">Exercise time (min)</td>
<td valign="top" align="center">6.3&#x2009;&#x00B1;&#x2009;0.7</td>
<td valign="top" align="center">7.7&#x2009;&#x00B1;&#x2009;0.6<xref ref-type="table-fn" rid="table-fn2">&#x002A;</xref></td>
<td valign="top" align="center">6.9&#x2009;&#x00B1;&#x2009;0.9</td>
<td valign="top" align="center">8.2&#x2009;&#x00B1;&#x2009;1.0<xref ref-type="table-fn" rid="table-fn2">&#x002A;</xref></td>
</tr>
<tr>
<td valign="top" align="left">Mean daily steps</td>
<td valign="top" align="center">6,316&#x2009;&#x00B1;&#x2009;1,033</td>
<td valign="top" align="center">9,173&#x2009;&#x00B1;&#x2009;1,596<xref ref-type="table-fn" rid="table-fn2">&#x002A;</xref></td>
<td valign="top" align="center">6,053&#x2009;&#x00B1;&#x2009;757</td>
<td valign="top" align="center">8,110&#x2009;&#x00B1;&#x2009;1,145<xref ref-type="table-fn" rid="table-fn2">&#x002A;</xref></td>
</tr>
<tr>
<td valign="top" align="left">Mean daily distance (km)</td>
<td valign="top" align="center">5.0&#x2009;&#x00B1;&#x2009;0.7</td>
<td valign="top" align="center">7.4&#x2009;&#x00B1;&#x2009;1.3<xref ref-type="table-fn" rid="table-fn2">&#x002A;</xref></td>
<td valign="top" align="center">5.1&#x2009;&#x00B1;&#x2009;1.1</td>
<td valign="top" align="center">6.4&#x2009;&#x00B1;&#x2009;0.9<xref ref-type="table-fn" rid="table-fn2">&#x002A;</xref></td>
</tr>
<tr>
<td valign="top" align="left">Mean daily calories (kcal)</td>
<td valign="top" align="center">272&#x2009;&#x00B1;&#x2009;122</td>
<td valign="top" align="center">464&#x2009;&#x00B1;&#x2009;262<xref ref-type="table-fn" rid="table-fn2">&#x002A;</xref></td>
<td valign="top" align="center">260&#x2009;&#x00B1;&#x2009;55</td>
<td valign="top" align="center">366&#x2009;&#x00B1;&#x2009;64<xref ref-type="table-fn" rid="table-fn2">&#x002A;</xref></td>
</tr>
<tr>
<td valign="top" align="left">Lean muscle mass (kg)</td>
<td valign="top" align="center">57.7&#x2009;&#x00B1;&#x2009;13.0</td>
<td valign="top" align="center">59.6&#x2009;&#x00B1;&#x2009;12.7<xref ref-type="table-fn" rid="table-fn2">&#x002A;</xref></td>
<td valign="top" align="center">56.3&#x2009;&#x00B1;&#x2009;6.4</td>
<td valign="top" align="center">58.7&#x2009;&#x00B1;&#x2009;7.7<xref ref-type="table-fn" rid="table-fn2">&#x002A;</xref></td>
</tr>
<tr>
<td valign="top" align="left">Fat mass (&#x0025;)</td>
<td valign="top" align="center">29.8&#x2009;&#x00B1;&#x2009;6.5</td>
<td valign="top" align="center">28.0&#x2009;&#x00B1;&#x2009;6.6<xref ref-type="table-fn" rid="table-fn2">&#x002A;</xref></td>
<td valign="top" align="center">29.5&#x2009;&#x00B1;&#x2009;3.3</td>
<td valign="top" align="center">27.8&#x2009;&#x00B1;&#x2009;3.3<xref ref-type="table-fn" rid="table-fn2">&#x002A;</xref></td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<fn id="table-fn2"><label>&#x002A;</label>
<p><italic>p</italic>&#x2009;&#x003C;&#x2009;0.001; within groups comparison.</p></fn>
</table-wrap-foot>
</table-wrap>
<p>The paired-sample <italic>t</italic>-test showed that all the assessed variables were statistically (i.e., <italic>p</italic>&#x2009;&#x003C;&#x2009;0.001) improved for both groups at 24 weeks (<xref ref-type="table" rid="T2">Table&#x00A0;2</xref>).</p>
<p>Pearson&#x0027;s r demonstrated positive correlations between VO<sub>2peak</sub> and mean daily distance (<italic>r</italic>&#x2009;&#x003D;&#x2009;0.375), and negative correlations between VO<sub>2peak</sub> and muscle (<italic>r</italic>&#x2009;&#x003D;&#x2009;&#x2212;0.523) and fat masses (<italic>r</italic>&#x2009;&#x003D;&#x2009;&#x2212;0.460).</p>
</sec>
<sec id="s5" sec-type="discussion"><title>Discussion</title>
<p>The current findings indicate that both groups significantly improved their VO<sub>2peak</sub>, mean daily steps, daily walked distance, daily calories, muscle mass, and fat percentage. Evidently, a 1&#x2005;ml&#x2005;kg<sup>&#x2212;1</sup>&#x2005;min<sup>&#x2212;1</sup> increase in VO<sub>2peak</sub> is directly associated with an approximately 10&#x0025; reduction in the risk of CVD mortality (<xref ref-type="bibr" rid="B22">22</xref>). In our study, the &#x0394;change (i.e., between the baseline and 6-month assessments) in VO<sub>2peak</sub> was found to be 2.8&#x2009;&#x00B1;&#x2009;1.9 and 2.2&#x2009;&#x00B1;&#x2009;1.5&#x2005;ml&#x2005;kg<sup>&#x2212;1</sup>&#x2005;min<sup>&#x2212;1</sup> for the gym-based and online groups, respectively. Therefore, the online-delivered home-based exercise programme, using digital technology to monitor the patient&#x0027;s physiological responses during exercise, seems to be effective in improving the CRF.</p>
<p>Mitochondrial biogenesis, induced by moderate-intensity aerobic exercise, is an important cellular organelle responsible for the oxidative activity of muscles (<xref ref-type="bibr" rid="B23">23</xref>). Considering that a minimum of 6&#x2005;weeks of moderate-intensity aerobic exercise is required to improve both the size and the number of mitochondria while also increasing the capacity for resynthesis of adenosine triphosphate (<xref ref-type="bibr" rid="B24">24</xref>), we prescribed our exercise protocol duration (i.e., 6 resynthesis months) to secure the establishment of this physiological adaptation for our participants. Another physiological adaptation to aerobic exercise is the increase in arteriovenous oxygen difference, which is directly related to increased VO<sub>2peak</sub>, via greater peripheral oxygen supply, corollary to the production of catecholamines, and increased nitric oxide bioavailability (<xref ref-type="bibr" rid="B25">25</xref>). Cardiac function also exhibits improved performance after an intervention with aerobic exercise (<xref ref-type="bibr" rid="B26">26</xref>). That is, the maximal cardiac output is improved after aerobic exercise as a result of an enlargement in cardiac dimension, improved contractility, and an increase in blood volume, allowing for greater filling of the ventricles and a consequently larger stroke volume (<xref ref-type="bibr" rid="B26">26</xref>).</p>
<p>Previous evidence has demonstrated the beneficial effects of CR to induce LV remodelling in patients with LV dysfunction after MI, and the benefits were even more pronounced at the post-MI acute phase of early CR (<xref ref-type="bibr" rid="B27">27</xref>). Beyond early CR, though, lifelong exercise seems to have the capability to preserve LV systolic function and potentially mitigate the adverse effects of LV remodelling after MI in veteran athletes (<xref ref-type="bibr" rid="B28">28</xref>). In addition, patients with acute MI who underwent early CR involving two different intensities (i.e., either high-interval training or continuous moderate intensity) for 12 weeks demonstrated a significant increase in VO<sub>2peak</sub> (<xref ref-type="bibr" rid="B29">29</xref>). Furthermore, the combination of RT and aerobic training has been demonstrated to be more effective in both strength and CRF than aerobic training alone (<xref ref-type="bibr" rid="B30">30</xref>). Therefore, it is evident that exercise training is able to effectively improve cardiac performance and CRF in MI patients.</p>
<p>Our exercise protocol was found to be effective in improving body composition by increasing lean muscle mass and reducing the percentage of fat mass in both exercise groups. In agreement with our findings, a recent systematic review indicated that RT not only could improve body composition but could also improve the haemodynamic parameters and exercise tolerance in patients with CAD (<xref ref-type="bibr" rid="B31">31</xref>). Thus, the RT component in our exercise programme could also promote improvements in VO<sub>2peak</sub> via haemodynamic upregulation, leading to increased exercise tolerance. That is, combined RT together with aerobic training can increase maximal and submaximal exercise tolerance with reduced haemodynamic responses and a decrease in blood lactate in patients with CAD (<xref ref-type="bibr" rid="B32">32</xref>). Furthermore, knowing that VT is a significant exercise parameter in CAD patients, combined exercise (i.e., RT and aerobic training) is able to increase this parameter by 32.8&#x0025; compared to 22.6&#x0025; with aerobic training alone (<xref ref-type="bibr" rid="B32">32</xref>). A previous study agrees with our findings, showing that a combined exercise protocol led to a significant increase in exercise tolerance and peak oxygen consumption in patients with CAD (<xref ref-type="bibr" rid="B33">33</xref>). These results might point to an improvement in muscular endurance. In our study, this could potentially explain the advantageous effect of the increase in daily steps for both exercise groups. Nevertheless, the method through which these parameters improve is not fully understood. Some of the physiological responses and training adaptations that exercise could promote are changes in the vasculature, which account for the increase in muscle blood flow, improvements in lactate clearance, skeletal muscle changes, and oxidative capability after exercise.</p>
<p>Our findings showed an overall positive correlation between VO<sub>2peak</sub> and mean daily distance, demonstrating how an improved CRF may lead to increased daily physical activity. The increased physical activity levels in CAD patients are of critical importance, with physical inactivity being adversely associated with the incidence of coronary heart disease (<xref ref-type="bibr" rid="B34">34</xref>). In addition, increased physical activity levels within the first year after MI were associated with reduced mortality (<xref ref-type="bibr" rid="B35">35</xref>). Therefore, our real-time online supervised exercise programme using wearable technology is able to increase the physical activity levels of post-MI patients with CAD.</p>
<p>Unlike mean daily distance, VO<sub>2peak</sub> was found to be negatively correlated with muscle and fat mass. It is well known that fat mass is negatively associated with VO<sub>2peak</sub> due to the physiological inability of this tissue to uptake and consume oxygen as opposed to muscle mass (<xref ref-type="bibr" rid="B36">36</xref>). Although we would expect a positive correlation between VO<sub>2peak</sub> and muscle mass (<xref ref-type="bibr" rid="B36">36</xref>), our results present the opposite. Generally, VO<sub>2peak</sub> declines gradually with advancing age, with a rate of approximately 10&#x0025; per decade after the age of 25 years. That is, it has been reported that VO<sub>2peak</sub> could decline by approximately 15&#x0025; between the ages of 50 and 75 years (<xref ref-type="bibr" rid="B37">37</xref>). Age-related decline in VO<sub>2peak</sub> results from multiple factors (e.g., decreased maximal HR and stroke volume, reductions due to heart and vascular dysfunction, and reduced peripheral oxygen extraction and maximal arterial-venous O<sub>2</sub> difference) (<xref ref-type="bibr" rid="B38">38</xref>, <xref ref-type="bibr" rid="B39">39</xref>). Another important factor in VO<sub>2peak</sub> decline is age-related muscle loss (sarcopenia) by the age of 50 years, which is estimated to be approximately 10&#x0025; of muscle area, and this rate demonstrates further increases in the following decades (<xref ref-type="bibr" rid="B40">40</xref>). Our study participants had a mean age of 54.1 and 53.5 years for the online and gym-based groups, respectively. Therefore, the negative correlation between VO<sub>2peak</sub> and muscle mass could potentially be explained by the age-related loss of muscle mass.</p>
<sec id="s5a"><title>Limitations</title>
<p>A limitation of our study could be that our participants were mainly men compared to women. However, a recent systematic review and meta-analysis reported that of a total of 361 post-MI patients, 82&#x0025; were men, which emphasises the prevalence of MI among men (<xref ref-type="bibr" rid="B41">41</xref>). Apparently, one of the risk factors for the development of this disease is sex, in addition to age (<xref ref-type="bibr" rid="B42">42</xref>). Oestrogen seems to be the main physiological protective factor in women. This hormone is strongly linked to cardiovascular protection (<xref ref-type="bibr" rid="B43">43</xref>). Apart from the sex factor, the incidence of MI appears in the 40&#x2013;45 years age group. At this age, oestrogen production in women is maintained. The prevalence of MI in women is increased after menopause, when there is a significant decrease in oestrogen production (<xref ref-type="bibr" rid="B43">43</xref>). Another limitation of our study may be the small sample size. For this reason, our results should be interpreted with caution.</p>
</sec>
</sec>
<sec id="s6" sec-type="conclusions"><title>Conclusion</title>
<p>Our findings indicate that a home-based online and real-time cardiac telerehabilitation programme could be as effective as a traditional gym-based cardiac rehabilitation programme (<xref ref-type="bibr" rid="B44">44</xref>&#x2013;<xref ref-type="bibr" rid="B46">46</xref>). That is, the online home-based group improved CRF significantly similar to the gym-based group, thus demonstrating its effectiveness. Future studies should explore the feasibility (i.e., adherence rates, health economics, and long-term survival rates) of such a real-time online cardiac telerehabilitation programme in a large population of patients after MI.</p>
</sec>
</body>
<back>
<sec id="s7" sec-type="data-availability"><title>Data availability statement</title>
<p>The raw data supporting the conclusions of this article will be made available by the authors, without undue reservation.</p>
</sec>
<sec id="s8" sec-type="ethics-statement"><title>Ethics statement</title>
<p>The studies involving humans were approved by the Research Ethics Committee of the School of Physical Education and Sport Science at Thessaloniki (Greece). The studies were conducted in accordance with local legislation and institutional requirements. The participants provided their written informed consent to participate in this study.</p>
</sec>
<sec id="s9" sec-type="author-contributions"><title>Author contributions</title>
<p>AM: Conceptualization, Formal Analysis, Methodology, Writing &#x2013; original draft, Writing &#x2013; review &#x0026; editing. MA: Conceptualization, Formal Analysis, Methodology, Writing &#x2013; original draft, Writing &#x2013; review &#x0026; editing. GK: Conceptualization, Formal Analysis, Methodology, Writing &#x2013; original draft, Writing &#x2013; review &#x0026; editing. AN: Formal Analysis, Methodology, Writing &#x2013; original draft, Writing &#x2013; review &#x0026; editing. KA: Formal Analysis, Methodology, Writing &#x2013; original draft, Writing &#x2013; review &#x0026; editing. EK: Conceptualization, Formal Analysis, Methodology, Supervision, Writing &#x2013; original draft, Writing &#x2013; review &#x0026; editing.</p>
</sec>
<sec id="s10" sec-type="funding-information"><title>Funding</title>
<p>The authors declare financial support was received for the research, authorship, and/or publication of this article.</p>
<p>This research was funded under the &#x2018;Innovation Investment Schemes&#x2019; in the framework of the Operational Program of Central Macedonia 2021&#x2013;2027 and it is co-funded by the European Social Fund through the National Strategic Reference Framework. Project code KMP6-0076626, MIS 6002766.</p>
</sec>
<ack><title>Acknowledgments</title>
<p>We would like to thank our participants for volunteering to take part in our study.</p>
</ack>
<sec id="s11" sec-type="COI-statement"><title>Conflict of interest</title>
<p>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</p>
</sec>
<sec id="s12" sec-type="disclaimer"><title>Publisher&#x0027;s note</title>
<p>All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.</p>
</sec>
<fn-group>
<title>Abbreviations</title>
<fn fn-type="abbr" id="ab001"><p>BMI, body mass index; BP, blood pressure; CAD, coronary artery disease; CPET, cardiopulmonary exercise test; CR, cardiac rehabilitation; CRF, cardiorespiratory fitness; CVD, cardiovascular disease; ECG, electrocardiogram; HF, heart failure; HR, heart rate; LV, left ventricle; LVEF, left ventricle ejection fraction; MI, myocardial infarction; QoL, quality of life; RER, respiratory exchange ratio; RPE, ratings of perceived exertion; RT, resistance training; SpO<sub>2</sub>, oxygen saturation; VO<sub>2peak</sub>, peak oxygen uptake; VT, ventilatory threshold.</p></fn>
</fn-group>
<ref-list><title>References</title>
<ref id="B1"><label>1.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Salari</surname><given-names>N</given-names></name><name><surname>Morddarvanjoghi</surname><given-names>F</given-names></name><name><surname>Abdolmaleki</surname><given-names>A</given-names></name><name><surname>Rasoulpoor</surname><given-names>S</given-names></name><name><surname>Khaleghi</surname><given-names>AA</given-names></name><name><surname>Hezarkhani</surname><given-names>LA</given-names></name><etal/></person-group> <article-title>The global prevalence of myocardial infarction: a systematic review and meta-analysis</article-title>. <source>BMC Cardiovasc Disord</source>. (<year>2023</year>) <volume>23</volume>(<issue>1</issue>):<fpage>206</fpage>. <pub-id pub-id-type="doi">10.1186/s12872-023-03231-w</pub-id><pub-id pub-id-type="pmid">37087452</pub-id></citation></ref>
<ref id="B2"><label>2.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Yeh</surname><given-names>RW</given-names></name><name><surname>Sidney</surname><given-names>S</given-names></name><name><surname>Chandra</surname><given-names>M</given-names></name><name><surname>Sorel</surname><given-names>M</given-names></name><name><surname>Selby</surname><given-names>JV</given-names></name><name><surname>Go</surname><given-names>AS</given-names></name></person-group>. <article-title>Population trends in the incidence and outcomes of acute myocardial infarction</article-title>. <source>N Engl J Med</source>. (<year>2010</year>) <volume>362</volume>(<issue>23</issue>):<fpage>2155</fpage>&#x2013;<lpage>65</lpage>. <pub-id pub-id-type="doi">10.1056/NEJMoa0908610</pub-id><pub-id pub-id-type="pmid">20558366</pub-id></citation></ref>
<ref id="B3"><label>3.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Tsao</surname><given-names>CW</given-names></name><name><surname>Aday</surname><given-names>AW</given-names></name><name><surname>Almarzooq</surname><given-names>ZI</given-names></name><name><surname>Anderson</surname><given-names>CAM</given-names></name><name><surname>Arora</surname><given-names>P</given-names></name><name><surname>Avery</surname><given-names>CL</given-names></name><etal/></person-group> <article-title>Heart disease and stroke statistics-2023 update: a report from the American Heart Association</article-title>. <source>Circulation</source>. (<year>2023</year>) <volume>147</volume>(<issue>8</issue>):<fpage>e93</fpage>&#x2013;<lpage>21</lpage>. <pub-id pub-id-type="doi">10.1161/CIR.0000000000001123</pub-id><pub-id pub-id-type="pmid">36695182</pub-id></citation></ref>
<ref id="B4"><label>4.</label><citation citation-type="book"><collab>OECD</collab>, <collab>European Observatory on Health Systems and Policies</collab>. <source>Greece: Country Health Profile 2023, State of Health in the EU</source>. <publisher-loc>Paris</publisher-loc>: <publisher-name>OECD Publishing</publisher-name> (<year>2023</year>). <pub-id pub-id-type="doi">10.1787/dd530c3e-en</pub-id></citation></ref>
<ref id="B5"><label>5.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Gikas</surname><given-names>A</given-names></name><name><surname>Lambadiari</surname><given-names>V</given-names></name><name><surname>Sotiropoulos</surname><given-names>A</given-names></name><name><surname>Panagiotakos</surname><given-names>D</given-names></name><name><surname>Pappas</surname><given-names>S</given-names></name></person-group>. <article-title>Prevalence of major cardiovascular risk factors and coronary heart disease in a sample of Greek adults: the Saronikos study</article-title>. <source>Open Cardiovasc Med J</source>. (<year>2016</year>) <volume>10</volume>:<fpage>69</fpage>&#x2013;<lpage>80</lpage>. <pub-id pub-id-type="doi">10.2174/1874192401610010069</pub-id><pub-id pub-id-type="pmid">27429668</pub-id></citation></ref>
<ref id="B6"><label>6.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Korzeniowska-Kubacka</surname><given-names>I</given-names></name><name><surname>Bili&#x0144;ska</surname><given-names>M</given-names></name><name><surname>Dobraszkiewicz-Wasilewska</surname><given-names>B</given-names></name><name><surname>Piotrowicz</surname><given-names>R</given-names></name></person-group>. <article-title>Hybrid model of cardiac rehabilitation in men and women after myocardial infarction</article-title>. <source>Cardiol J</source>. (<year>2015</year>) <volume>22</volume>(<issue>2</issue>):<fpage>212</fpage>&#x2013;<lpage>8</lpage>. <pub-id pub-id-type="doi">10.5603/CJ.a2015.0004</pub-id><pub-id pub-id-type="pmid">25588535</pub-id></citation></ref>
<ref id="B7"><label>7.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Lim</surname><given-names>S</given-names></name><name><surname>Han</surname><given-names>J</given-names></name><name><surname>Choe</surname><given-names>Y</given-names></name></person-group>. <article-title>Comparison of the effects of cardiac rehabilitation between obese and non-obese patients after acute myocardial infarction</article-title>. <source>Ann Rehabil Med</source>. (<year>2016</year>) <volume>40</volume>(<issue>5</issue>):<fpage>924</fpage>&#x2013;<lpage>32</lpage>. <pub-id pub-id-type="doi">10.5535/arm.2016.40.5.924</pub-id><pub-id pub-id-type="pmid">27847723</pub-id></citation></ref>
<ref id="B8"><label>8.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Dalal</surname><given-names>JJ</given-names></name><name><surname>Almahmeed</surname><given-names>W</given-names></name><name><surname>Krittayaphong</surname><given-names>R</given-names></name><name><surname>Nicholls</surname><given-names>SJ</given-names></name><name><surname>Soomro</surname><given-names>K</given-names></name><name><surname>Yeo</surname><given-names>KK</given-names></name></person-group>. <article-title>Consensus recommendations of the Asia Pacific Cardiometabolic Consortium on Secondary Prevention Strategies in Myocardial Infarction: recommendations on pharmacotherapy, lifestyle modification and cardiac rehabilitation</article-title>. <source>J Asian Pac Soc Cardiol</source>. (<year>2023</year>) <volume>2</volume>:<fpage>e01</fpage>. <pub-id pub-id-type="doi">10.15420/japsc.2022.24</pub-id></citation></ref>
<ref id="B9"><label>9.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Antoniou</surname><given-names>V</given-names></name><name><surname>Pasias</surname><given-names>K</given-names></name><name><surname>Loukidis</surname><given-names>N</given-names></name><name><surname>Exarchou-Kouveli</surname><given-names>KK</given-names></name><name><surname>Panagiotakos</surname><given-names>DB</given-names></name><name><surname>Grace</surname><given-names>SL</given-names></name><etal/></person-group> <article-title>Translation, cross-cultural adaptation and psychometric validation of the Greek version of the cardiac rehabilitation barriers scale (CRBS-GR): what are the barriers in South-East Europe?</article-title> <source>Int J Environ Res Public Health</source>. (<year>2023</year>) <volume>20</volume>(<issue>5</issue>):<fpage>4064</fpage>. <pub-id pub-id-type="doi">10.3390/ijerph20054064</pub-id><pub-id pub-id-type="pmid">36901075</pub-id></citation></ref>
<ref id="B10"><label>10.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Batalik</surname><given-names>L</given-names></name><name><surname>Filakova</surname><given-names>K</given-names></name><name><surname>Batalikova</surname><given-names>K</given-names></name><name><surname>Dosbaba</surname><given-names>F</given-names></name></person-group>. <article-title>Remotely monitored telerehabilitation for cardiac patients: a review of the current situation</article-title>. <source>World J Clin Cases</source>. (<year>2020</year>) <volume>8</volume>(<issue>10</issue>):<fpage>1818</fpage>&#x2013;<lpage>31</lpage>. <pub-id pub-id-type="doi">10.12998/wjcc.v8.i10.1818</pub-id><pub-id pub-id-type="pmid">32518772</pub-id></citation></ref>
<ref id="B11"><label>11.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Antoniou</surname><given-names>V</given-names></name><name><surname>Davos</surname><given-names>CH</given-names></name><name><surname>Kapreli</surname><given-names>E</given-names></name><name><surname>Batalik</surname><given-names>L</given-names></name><name><surname>Panagiotakos</surname><given-names>DB</given-names></name><name><surname>Pepera</surname><given-names>G</given-names></name></person-group>. <article-title>Effectiveness of home-based cardiac rehabilitation, using wearable sensors, as a multicomponent, cutting-edge intervention: a systematic review and meta-analysis</article-title>. <source>J Clin Med</source>. (<year>2022</year>) <volume>11</volume>(<issue>13</issue>):<fpage>3772</fpage>. <pub-id pub-id-type="doi">10.3390/jcm11133772</pub-id><pub-id pub-id-type="pmid">35807055</pub-id></citation></ref>
<ref id="B12"><label>12.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Mezzani</surname><given-names>A</given-names></name><name><surname>Hamm</surname><given-names>LF</given-names></name><name><surname>Jones</surname><given-names>AM</given-names></name><name><surname>McBride</surname><given-names>PE</given-names></name><name><surname>Moholdt</surname><given-names>T</given-names></name><name><surname>Stone</surname><given-names>JA</given-names></name><etal/></person-group> <article-title>Aerobic exercise intensity assessment and prescription in cardiac rehabilitation: a joint position statement of the European association for cardiovascular prevention and rehabilitation, the American Association of Cardiovascular and Pulmonary Rehabilitation and the Canadian Association of Cardiac Rehabilitation</article-title>. <source>Eur J Prev Cardiol</source>. (<year>2013</year>) <volume>20</volume>(<issue>3</issue>):<fpage>442</fpage>&#x2013;<lpage>67</lpage>. <pub-id pub-id-type="doi">10.1177/2047487312460484</pub-id><pub-id pub-id-type="pmid">23104970</pub-id></citation></ref>
<ref id="B13"><label>13.</label><citation citation-type="book"><article-title>General principles of exercise prescription</article-title>. In: <person-group person-group-type="editor"><name><surname>Thompson</surname><given-names>WR</given-names></name><name><surname>Gordon</surname><given-names>NF</given-names></name><name><surname>Pescatello</surname><given-names>LS</given-names></name></person-group>, editors. <source>ACSM&#x2019;s Guidelines for Exercise Testing and Prescription</source>. <publisher-loc>Philadelphia</publisher-loc>, <publisher-loc>PA</publisher-loc>: <publisher-name>Wolters Kluwer/Lippincott Williams &#x0026; Wilkins</publisher-name> (<year>2010</year>). p. <fpage>152</fpage>&#x2013;<lpage>82</lpage>.</citation></ref>
<ref id="B14"><label>14.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Demopoulos</surname><given-names>L</given-names></name><name><surname>Bijou</surname><given-names>R</given-names></name><name><surname>Fergus</surname><given-names>I</given-names></name><name><surname>Jones</surname><given-names>M</given-names></name><name><surname>Strom</surname><given-names>J</given-names></name><name><surname>LeJemtel</surname><given-names>TH</given-names></name></person-group>. <article-title>Exercise training in patients with severe congestive heart failure: enhancing peak aerobic capacity while minimizing the increase in ventricular wall stress</article-title>. <source>J Am Coll Cardiol</source>. (<year>1997</year>) <volume>29</volume>(<issue>3</issue>):<fpage>597</fpage>&#x2013;<lpage>603</lpage>. <pub-id pub-id-type="doi">10.1016/s0735-1097(96)00526-8</pub-id><pub-id pub-id-type="pmid">9060899</pub-id></citation></ref>
<ref id="B15"><label>15.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Baschung Pfister</surname><given-names>P</given-names></name><name><surname>de Bruin</surname><given-names>ED</given-names></name><name><surname>Tobler-Ammann</surname><given-names>BC</given-names></name><name><surname>Maurer</surname><given-names>B</given-names></name><name><surname>Knols</surname><given-names>RH</given-names></name></person-group>. <article-title>The relevance of applying exercise training principles when designing therapeutic interventions for patients with inflammatory myopathies: a systematic review</article-title>. <source>Rheumatol Int</source>. (<year>2015</year>) <volume>35</volume>(<issue>10</issue>):<fpage>1641</fpage>&#x2013;<lpage>54</lpage>. <pub-id pub-id-type="doi">10.1007/s00296-015-3343-9</pub-id><pub-id pub-id-type="pmid">26271469</pub-id></citation></ref>
<ref id="B16"><label>16.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Fan</surname><given-names>Y</given-names></name><name><surname>Yu</surname><given-names>M</given-names></name><name><surname>Li</surname><given-names>J</given-names></name><name><surname>Zhang</surname><given-names>H</given-names></name><name><surname>Liu</surname><given-names>Q</given-names></name><name><surname>Zhao</surname><given-names>L</given-names></name><etal/></person-group> <article-title>Efficacy and safety of resistance training for coronary heart disease rehabilitation: a systematic review of randomized controlled trials</article-title>. <source>Front Cardiovasc Med</source>. (<year>2021</year>) <volume>8</volume>:<fpage>754794</fpage>. <pub-id pub-id-type="doi">10.3389/fcvm.2021.754794</pub-id><pub-id pub-id-type="pmid">34805309</pub-id></citation></ref>
<ref id="B17"><label>17.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Carbone</surname><given-names>S</given-names></name><name><surname>Billingsley</surname><given-names>HE</given-names></name><name><surname>Rodriguez-Miguelez</surname><given-names>P</given-names></name><name><surname>Kirkman</surname><given-names>DL</given-names></name><name><surname>Garten</surname><given-names>R</given-names></name><name><surname>Franco</surname><given-names>RL</given-names></name><etal/></person-group> <article-title>Lean mass abnormalities in heart failure: the role of sarcopenia, sarcopenic obesity, and cachexia</article-title>. <source>Curr Probl Cardiol</source>. (<year>2020</year>) <volume>45</volume>(<issue>11</issue>):<fpage>100417</fpage>. <pub-id pub-id-type="doi">10.1016/j.cpcardiol.2019.03.006</pub-id><pub-id pub-id-type="pmid">31036371</pub-id></citation></ref>
<ref id="B18"><label>18.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Damluji</surname><given-names>AA</given-names></name><name><surname>Alfaraidhy</surname><given-names>M</given-names></name><name><surname>AlHajri</surname><given-names>N</given-names></name><name><surname>Rohant</surname><given-names>NN</given-names></name><name><surname>Kumar</surname><given-names>M</given-names></name><name><surname>Al Malouf</surname><given-names>C</given-names></name><etal/></person-group> <article-title>Sarcopenia and cardiovascular diseases</article-title>. <source>Circulation</source>. (<year>2023</year>) <volume>147</volume>(<issue>20</issue>):<fpage>1534</fpage>&#x2013;<lpage>53</lpage>. <pub-id pub-id-type="doi">10.1161/CIRCULATIONAHA.123.064071</pub-id><pub-id pub-id-type="pmid">37186680</pub-id></citation></ref>
<ref id="B19"><label>19.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Kirkman</surname><given-names>DL</given-names></name><name><surname>Lee</surname><given-names>D</given-names></name><name><surname>Carbone</surname><given-names>S</given-names></name></person-group>. <article-title>Resistance exercise for cardiac rehabilitation</article-title>. <source>Prog Cardiovasc Dis</source>. (<year>2022</year>) <volume>70</volume>:<fpage>66</fpage>&#x2013;<lpage>72</lpage>. <pub-id pub-id-type="doi">10.1016/j.pcad.2022.01.004</pub-id><pub-id pub-id-type="pmid">35122871</pub-id></citation></ref>
<ref id="B20"><label>20.</label><citation citation-type="other"><collab>AHA. American Heart Association</collab>. (<year>2018</year>). <comment>Available online at:</comment> <ext-link ext-link-type="uri" xlink:href="https://www.heart.org/en/health-topics/cardiac-rehab/getting-physically-active/strength-and-balance-exercises">https://www.heart.org/en/health-topics/cardiac-rehab/getting-physically-active/strength-and-balance-exercises</ext-link> (Accessed January 15, 2024).</citation></ref>
<ref id="B21"><label>21.</label><citation citation-type="other"><collab>AHA. American Heart Association</collab>. (<year>2018</year>). <comment>Available online at:</comment> <ext-link ext-link-type="uri" xlink:href="https://www.heart.org/en/health-topics/cardiac-rehab/getting-physically-active/stretching-and-flexibility-exercises">https://www.heart.org/en/health-topics/cardiac-rehab/getting-physically-active/stretching-and-flexibility-exercises</ext-link> (Accessed January 15, 2024).</citation></ref>
<ref id="B22"><label>22.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Kavanagh</surname><given-names>T</given-names></name><name><surname>Mertens</surname><given-names>DJ</given-names></name><name><surname>Hamm</surname><given-names>LF</given-names></name><name><surname>Beyene</surname><given-names>J</given-names></name><name><surname>Kennedy</surname><given-names>J</given-names></name><name><surname>Corey</surname><given-names>P</given-names></name><etal/></person-group> <article-title>Prediction of long-term prognosis in 12,169 men referred for cardiac rehabilitation</article-title>. <source>Circulation</source>. (<year>2002</year>) <volume>106</volume>(<issue>6</issue>):<fpage>666</fpage>&#x2013;<lpage>71</lpage>. <pub-id pub-id-type="doi">10.1161/01.cir.0000024413.15949.ed</pub-id><pub-id pub-id-type="pmid">12163425</pub-id></citation></ref>
<ref id="B23"><label>23.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Distefano</surname><given-names>G</given-names></name><name><surname>Goodpaster</surname><given-names>BH</given-names></name></person-group>. <article-title>Effects of exercise and aging on skeletal muscle</article-title>. <source>Cold Spring Harb Perspect Med</source>. (<year>2018</year>) <volume>8</volume>(<issue>3</issue>):<fpage>a029785</fpage>. <pub-id pub-id-type="doi">10.1101/cshperspect.a029785</pub-id><pub-id pub-id-type="pmid">28432116</pub-id></citation></ref>
<ref id="B24"><label>24.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Clark</surname><given-names>JE</given-names></name></person-group>. <article-title>The impact of duration on effectiveness of exercise, the implication for periodization of training and goal setting for individuals who are overfat, a meta-analysis</article-title>. <source>Biol Sport</source>. (<year>2016</year>) <volume>33</volume>(<issue>4</issue>):<fpage>309</fpage>&#x2013;<lpage>33</lpage>. <pub-id pub-id-type="doi">10.5604/20831862.1212974</pub-id><pub-id pub-id-type="pmid">28090136</pub-id></citation></ref>
<ref id="B25"><label>25.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Di Francescomarino</surname><given-names>S</given-names></name><name><surname>Sciartilli</surname><given-names>A</given-names></name><name><surname>Di Valerio</surname><given-names>V</given-names></name><name><surname>Di Baldassarre</surname><given-names>A</given-names></name><name><surname>Gallina</surname><given-names>S</given-names></name></person-group>. <article-title>The effect of physical exercise on endothelial function</article-title>. <source>Sports Med</source>. (<year>2009</year>) <volume>39</volume>(<issue>10</issue>):<fpage>797</fpage>&#x2013;<lpage>812</lpage>. <pub-id pub-id-type="doi">10.2165/11317750-000000000-00000</pub-id><pub-id pub-id-type="pmid">19757859</pub-id></citation></ref>
<ref id="B26"><label>26.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Hellsten</surname><given-names>Y</given-names></name><name><surname>Nyberg</surname><given-names>M</given-names></name></person-group>. <article-title>Cardiovascular adaptations to exercise training</article-title>. <source>Compr Physiol</source>. (<year>2015</year>) <volume>6</volume>(<issue>1</issue>):<fpage>1</fpage>&#x2013;<lpage>32</lpage>. <pub-id pub-id-type="doi">10.1002/cphy.c140080</pub-id><pub-id pub-id-type="pmid">26756625</pub-id></citation></ref>
<ref id="B27"><label>27.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname><given-names>Y</given-names></name><name><surname>Lu</surname><given-names>Y</given-names></name><name><surname>Tang</surname><given-names>Y</given-names></name><name><surname>Yang</surname><given-names>D</given-names></name><name><surname>Wu</surname><given-names>HF</given-names></name><name><surname>Bian</surname><given-names>ZP</given-names></name><etal/></person-group> <article-title>The effects of different initiation time of exercise training on left ventricular remodeling and cardiopulmonary rehabilitation in patients with left ventricular dysfunction after myocardial infarction</article-title>. <source>Disabil Rehabil</source>. (<year>2016</year>) <volume>38</volume>(<issue>3</issue>):<fpage>268</fpage>&#x2013;<lpage>76</lpage>. <pub-id pub-id-type="doi">10.3109/09638288.2015.1036174</pub-id><pub-id pub-id-type="pmid">25885667</pub-id></citation></ref>
<ref id="B28"><label>28.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Maessen</surname><given-names>MF</given-names></name><name><surname>Eijsvogels</surname><given-names>TM</given-names></name><name><surname>Stevens</surname><given-names>G</given-names></name><name><surname>van Dijk</surname><given-names>AP</given-names></name><name><surname>Hopman</surname><given-names>MT</given-names></name></person-group>. <article-title>Benefits of lifelong exercise training on left ventricular function after myocardial infarction</article-title>. <source>Eur J Prev Cardiol</source>. (<year>2017</year>) <volume>24</volume>(<issue>17</issue>):<fpage>1856</fpage>&#x2013;<lpage>66</lpage>. <pub-id pub-id-type="doi">10.1177/2047487317728765</pub-id><pub-id pub-id-type="pmid">28862031</pub-id></citation></ref>
<ref id="B29"><label>29.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Santi</surname><given-names>GLD</given-names></name><name><surname>Moreira</surname><given-names>HT</given-names></name><name><surname>Carvalho</surname><given-names>E</given-names></name><name><surname>Cresc&#x00EA;ncio</surname><given-names>JC</given-names></name><name><surname>Schmidt</surname><given-names>A</given-names></name><name><surname>Marin-Neto</surname><given-names>JA</given-names></name><etal/></person-group> <article-title>Influence of aerobic training on the mechanics of ventricular contraction after acute myocardial infarction: a pilot study</article-title>. <source>Arq Bras Cardiol</source>. (<year>2018</year>) <volume>110</volume>(<issue>4</issue>):<fpage>383</fpage>&#x2013;<lpage>7</lpage>. <pub-id pub-id-type="doi">10.5935/abc.20180049</pub-id><pub-id pub-id-type="pmid">29791580</pub-id></citation></ref>
<ref id="B30"><label>30.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Ostman</surname><given-names>C</given-names></name><name><surname>Jewiss</surname><given-names>D</given-names></name><name><surname>Smart</surname><given-names>NA</given-names></name></person-group>. <article-title>The effect of exercise training intensity on quality of life in heart failure patients: a systematic review and meta-analysis</article-title>. <source>Cardiology</source>. (<year>2017</year>) <volume>136</volume>(<issue>2</issue>):<fpage>79</fpage>&#x2013;<lpage>89</lpage>. <pub-id pub-id-type="doi">10.1159/000448088</pub-id><pub-id pub-id-type="pmid">27577715</pub-id></citation></ref>
<ref id="B31"><label>31.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Sharma</surname><given-names>A</given-names></name><name><surname>Sharma</surname><given-names>N</given-names></name><name><surname>Vats</surname><given-names>S</given-names></name><name><surname>Jain</surname><given-names>M</given-names></name><name><surname>Chahal</surname><given-names>A</given-names></name><name><surname>Kashoo</surname><given-names>FZ</given-names></name><etal/></person-group> <article-title>Effect of resistance training on body composition, hemodynamic parameters and exercise tolerance among patients with coronary artery disease: a systematic review</article-title>. <source>Healthcare (Basel)</source>. (<year>2022</year>) <volume>11</volume>(<issue>1</issue>):<fpage>131</fpage>. <pub-id pub-id-type="doi">10.3390/healthcare11010131</pub-id><pub-id pub-id-type="pmid">36611590</pub-id></citation></ref>
<ref id="B32"><label>32.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Santa-Clara</surname><given-names>H</given-names></name><name><surname>Fernhall</surname><given-names>B</given-names></name><name><surname>Mendes</surname><given-names>M</given-names></name><name><surname>Sardinha</surname><given-names>LB</given-names></name></person-group>. <article-title>Effect of a 1 year combined aerobic- and weight-training exercise programme on aerobic capacity and ventilatory threshold in patients suffering from coronary artery disease</article-title>. <source>Eur J Appl Physiol</source>. (<year>2002</year>) <volume>87</volume>(<issue>6</issue>):<fpage>568</fpage>&#x2013;<lpage>75</lpage>. <pub-id pub-id-type="doi">10.1007/s00421-002-0675-4</pub-id><pub-id pub-id-type="pmid">12355198</pub-id></citation></ref>
<ref id="B33"><label>33.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Caruso</surname><given-names>FR</given-names></name><name><surname>Bonjorno</surname><given-names>JCJ</given-names></name><name><surname>Arena</surname><given-names>R</given-names></name><name><surname>Phillips</surname><given-names>SA</given-names></name><name><surname>Cabiddu</surname><given-names>R</given-names></name><name><surname>Mendes</surname><given-names>RG</given-names></name><etal/></person-group> <article-title>Hemodynamic, autonomic, ventilatory, and metabolic alterations after resistance training in patients with coronary artery disease: a randomized controlled trial</article-title>. <source>Am J Phys Med Rehabil</source>. (<year>2017</year>) <volume>96</volume>(<issue>4</issue>):<fpage>226</fpage>&#x2013;<lpage>35</lpage>. <pub-id pub-id-type="doi">10.1097/PHM.0000000000000568</pub-id><pub-id pub-id-type="pmid">27386813</pub-id></citation></ref>
<ref id="B34"><label>34.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Franklin</surname><given-names>BA</given-names></name><name><surname>Eijsvogels</surname><given-names>TMH</given-names></name><name><surname>Pandey</surname><given-names>A</given-names></name><name><surname>Quindry</surname><given-names>J</given-names></name><name><surname>Toth</surname><given-names>PP</given-names></name></person-group>. <article-title>Physical activity, cardiorespiratory fitness, and cardiovascular health: a clinical practice statement of the American Society for Preventive Cardiology part II: physical activity, cardiorespiratory fitness, minimum and goal intensities for exercise training, prescriptive methods, and special patient populations</article-title>. <source>Am J Prev Cardiol</source>. (<year>2022</year>) <volume>12</volume>:<fpage>100425</fpage>. <pub-id pub-id-type="doi">10.1016/j.ajpc.2022.100425</pub-id><pub-id pub-id-type="pmid">36281325</pub-id></citation></ref>
<ref id="B35"><label>35.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Ekblom</surname><given-names>O</given-names></name><name><surname>Ek</surname><given-names>A</given-names></name><name><surname>Cider</surname><given-names>&#x00C5;</given-names></name><name><surname>Hambraeus</surname><given-names>K</given-names></name><name><surname>B&#x00F6;rjesson</surname><given-names>M</given-names></name></person-group>. <article-title>Increased physical activity post-myocardial infarction is related to reduced mortality: results from the SWEDEHEART registry</article-title>. <source>J Am Heart Assoc</source>. (<year>2018</year>) <volume>7</volume>(<issue>24</issue>):<fpage>e010108</fpage>. <pub-id pub-id-type="doi">10.1161/JAHA.118.010108</pub-id><pub-id pub-id-type="pmid">30561263</pub-id></citation></ref>
<ref id="B36"><label>36.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Vargas</surname><given-names>VZ</given-names></name><name><surname>Lira</surname><given-names>C</given-names></name><name><surname>Vancini</surname><given-names>RL</given-names></name><name><surname>Rayes</surname><given-names>ABR</given-names></name><name><surname>Andrade</surname><given-names>MS</given-names></name></person-group>. <article-title>Fat mass is negatively associated with the physiological ability of tissue to consume oxygen</article-title>. <source>Motriz</source>. (<year>2018</year>) <volume>24</volume>:11104. <pub-id pub-id-type="doi">10.1590/s1980-6574201800040010</pub-id></citation></ref>
<ref id="B37"><label>37.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Hawkins</surname><given-names>S</given-names></name><name><surname>Wiswell</surname><given-names>R</given-names></name></person-group>. <article-title>Rate and mechanism of maximal oxygen consumption decline with aging: implications for exercise training</article-title>. <source>Sports Med</source>. (<year>2003</year>) <volume>33</volume>(<issue>12</issue>):<fpage>877</fpage>&#x2013;<lpage>88</lpage>. <pub-id pub-id-type="doi">10.2165/00007256-200333120-00002</pub-id><pub-id pub-id-type="pmid">12974656</pub-id></citation></ref>
<ref id="B38"><label>38.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Tanaka</surname><given-names>H</given-names></name><name><surname>Seals</surname><given-names>DR</given-names></name></person-group>. <article-title>Endurance exercise performance in masters athletes: age-associated changes and underlying physiological mechanisms</article-title>. <source>J Physiol</source>. (<year>2008</year>) <volume>586</volume>(<issue>1</issue>):<fpage>55</fpage>&#x2013;<lpage>63</lpage>. <pub-id pub-id-type="doi">10.1113/jphysiol.2007.141879</pub-id><pub-id pub-id-type="pmid">17717011</pub-id></citation></ref>
<ref id="B39"><label>39.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>North</surname><given-names>BJ</given-names></name><name><surname>Sinclair</surname><given-names>DA</given-names></name></person-group>. <article-title>The intersection between aging and cardiovascular disease</article-title>. <source>Circ Res</source>. (<year>2012</year>) <volume>110</volume>(<issue>8</issue>):<fpage>1097</fpage>&#x2013;<lpage>108</lpage>. <pub-id pub-id-type="doi">10.1161/CIRCRESAHA.111.246876</pub-id><pub-id pub-id-type="pmid">22499900</pub-id></citation></ref>
<ref id="B40"><label>40.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Kim</surname><given-names>C</given-names></name><name><surname>Wheatley</surname><given-names>CM</given-names></name><name><surname>Behnia</surname><given-names>M</given-names></name><name><surname>Johnson</surname><given-names>BD</given-names></name></person-group>. <article-title>The effect of aging on relationships between lean body mass and VO2max in rowers</article-title>. <source>PLoS ONE</source>. (<year>2016</year>) <volume>11</volume>(<issue>8</issue>):<fpage>e0160275</fpage>. <pub-id pub-id-type="doi">10.1371/journal.pone.0160275</pub-id><pub-id pub-id-type="pmid">27479009</pub-id></citation></ref>
<ref id="B41"><label>41.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Ribeiro</surname><given-names>ALP</given-names></name><name><surname>Duncan</surname><given-names>BB</given-names></name><name><surname>Brant</surname><given-names>LCC</given-names></name><name><surname>Lotufo</surname><given-names>PA</given-names></name><name><surname>Mill</surname><given-names>JG</given-names></name><name><surname>Barreto</surname><given-names>SM</given-names></name></person-group>. <article-title>Cardiovascular health in Brazil: trends and perspectives</article-title>. <source>Circulation</source>. (<year>2016</year>) <volume>133</volume>(<issue>4</issue>):<fpage>422</fpage>&#x2013;<lpage>33</lpage>. <pub-id pub-id-type="doi">10.1161/CIRCULATIONAHA.114.008727</pub-id><pub-id pub-id-type="pmid">26811272</pub-id></citation></ref>
<ref id="B42"><label>42.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Schulte</surname><given-names>KJ</given-names></name><name><surname>Mayrovitz</surname><given-names>HN</given-names></name></person-group>. <article-title>Myocardial infarction signs and symptoms: females vs. males</article-title>. <source>Cureus</source>. (<year>2023</year>) <volume>15</volume>(<issue>4</issue>):<fpage>e37522</fpage>. <pub-id pub-id-type="doi">10.7759/cureus.37522</pub-id><pub-id pub-id-type="pmid">37193476</pub-id></citation></ref>
<ref id="B43"><label>43.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Iorga</surname><given-names>A</given-names></name><name><surname>Cunningham</surname><given-names>CM</given-names></name><name><surname>Moazeni</surname><given-names>S</given-names></name><name><surname>Ruffenach</surname><given-names>G</given-names></name><name><surname>Umar</surname><given-names>S</given-names></name><name><surname>Eghbali</surname><given-names>M</given-names></name></person-group>. <article-title>The protective role of estrogen and estrogen receptors in cardiovascular disease and the controversial use of estrogen therapy</article-title>. <source>Biol Sex Differ</source>. (<year>2017</year>) <volume>8</volume>(<issue>1</issue>):<fpage>33</fpage>&#x2013;<lpage>8</lpage>. <pub-id pub-id-type="doi">10.1186/s13293-017-0152-8</pub-id><pub-id pub-id-type="pmid">29065927</pub-id></citation></ref>
<ref id="B44"><label>44.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Thomas</surname><given-names>RJ</given-names></name><name><surname>Beatty</surname><given-names>AL</given-names></name><name><surname>Beckie</surname><given-names>TM</given-names></name><name><surname>Brewer</surname><given-names>LC</given-names></name><name><surname>Brown</surname><given-names>TM</given-names></name><name><surname>Forman</surname><given-names>DE</given-names></name><etal/></person-group> <article-title>Home-based cardiac rehabilitation: a scientific statement from the American Association of Cardiovascular and Pulmonary Rehabilitation, the American Heart Association, and the American College of Cardiology</article-title>. <source>Circulation</source>. (<year>2019</year>) <volume>140</volume>(<issue>1</issue>):<fpage>e69</fpage>&#x2013;<lpage>89</lpage>. <pub-id pub-id-type="doi">10.1161/CIR.0000000000000663</pub-id><pub-id pub-id-type="pmid">31082266</pub-id></citation></ref>
<ref id="B45"><label>45.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Su</surname><given-names>JJ</given-names></name><name><surname>Yu</surname><given-names>DSF</given-names></name><name><surname>Paguio</surname><given-names>JT</given-names></name></person-group>. <article-title>Effect of eHealth cardiac rehabilitation on health outcomes of coronary heart disease patients: a systematic review and meta-analysis</article-title>. <source>J Adv Nurs</source>. (<year>2020</year>) <volume>76</volume>(<issue>3</issue>):<fpage>754</fpage>&#x2013;<lpage>72</lpage>. <pub-id pub-id-type="doi">10.1111/jan.14272</pub-id><pub-id pub-id-type="pmid">31769527</pub-id></citation></ref>
<ref id="B46"><label>46.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Rawstorn</surname><given-names>JC</given-names></name><name><surname>Gant</surname><given-names>N</given-names></name><name><surname>Direito</surname><given-names>A</given-names></name><name><surname>Beckmann</surname><given-names>C</given-names></name><name><surname>Maddison</surname><given-names>R</given-names></name></person-group>. <article-title>Telehealth exercise-based cardiac rehabilitation: a systematic review and meta-analysis</article-title>. <source>Heart</source>. (<year>2016</year>) <volume>102</volume>(<issue>15</issue>):<fpage>1183</fpage>&#x2013;<lpage>92</lpage>. <pub-id pub-id-type="doi">10.1136/heartjnl-2015-308966</pub-id><pub-id pub-id-type="pmid">26936337</pub-id></citation></ref></ref-list>
</back>
</article>